Bruker Historical Financial Ratios

BRKR Stock  USD 50.82  2.10  3.97%   
Bruker is presently reporting on over 113 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0033, PTB Ratio of 14.38 or Free Cash Flow Yield of 0.0149 will help investors to properly organize and evaluate Bruker financial condition quickly.
Quick RatioCurrent Ratio1.881.450.991.141.502.632.321.802.072.44100%
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

About Bruker Financial Ratios Analysis

BrukerFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bruker investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bruker financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bruker history.

Bruker Financial Ratios Chart

At this time, Bruker's Research And Ddevelopement To Revenue is relatively stable compared to the past year. As of 02/23/2025, Capex To Revenue is likely to grow to 0.05, while Free Cash Flow Yield is likely to drop 0.01.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioFree Cash Flow Yield
Operating Cash Flow Per ShareStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Payables TurnoverSales General And Administrative To Revenue
Research And Ddevelopement To RevenueCapex To Revenue
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioIncome Quality
RoePe Ratio
Return On Tangible AssetsEarnings Yield
Intangibles To Total AssetsCurrent Ratio
Receivables TurnoverDebt To Equity
Capex Per ShareRevenue Per Share
Debt To AssetsDays Sales Outstanding
Book Value Per ShareInvested Capital
Average PayablesEv To Sales
Days Of Inventory On HandAverage Inventory
Cash Per ShareDays Payables Outstanding
Net Current Asset ValueTangible Asset Value
Ev To Operating Cash FlowEv To Free Cash Flow
Net Debt To E B I T D ATangible Book Value Per Share
Graham NumberShareholders Equity Per Share
Graham Net NetAverage Receivables
Interest Debt Per ShareEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioOperating Cash Flow Sales Ratio
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Days Of Payables OutstandingCash Conversion Cycle
Days Of Inventory OutstandingDays Of Sales Outstanding
Enterprise Value Multiple
JavaScript chart by amCharts 3.21.1520152020202522.533.544.5 0.0020.00250.0030.00350.0040.00450.0050.00550.0060.00650.007 567891011121314 0.0150.020.0250.030.0350.04 0.050.060.070.080.090.10.11 253035404550556065
JavaScript chart by amCharts 3.21.15Price To Sales Ratiototal: 40.55681830415152Dividend Yieldtotal: 0.05313573642196708Ptb Ratiototal: 96.346965006558Free Cash Flow Yieldtotal: 0.2889412357724993Roictotal: 1.1086735319633625Price To Free Cash Flows Ratiototal: 571.0785614285479

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Bruker stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Bruker sales, a figure that is much harder to manipulate than other Bruker multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Bruker dividend as a percentage of Bruker stock price. Bruker dividend yield is a measure of Bruker stock productivity, which can be interpreted as interest rate earned on an Bruker investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.
Most ratios from Bruker's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bruker current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.At this time, Bruker's Research And Ddevelopement To Revenue is relatively stable compared to the past year. As of 02/23/2025, Capex To Revenue is likely to grow to 0.05, while Free Cash Flow Yield is likely to drop 0.01.
 2022 2023 2024 2025 (projected)
Dividend Yield0.0029340.0027330.0034460.003274
Price To Sales Ratio4.013.632.595.09

Bruker fundamentals Correlations

0.880.99-0.57-0.33-0.130.99-0.33-0.49-0.55-0.22-0.620.730.99-0.240.560.610.980.78-0.070.98-0.36-0.58-0.61-0.45-0.19
0.880.92-0.38-0.680.030.92-0.62-0.53-0.34-0.49-0.250.480.9-0.320.650.620.950.81-0.40.95-0.6-0.43-0.84-0.630.1
0.990.92-0.56-0.41-0.091.0-0.41-0.51-0.54-0.29-0.570.70.99-0.30.610.640.990.81-0.120.99-0.4-0.58-0.67-0.51-0.17
-0.57-0.38-0.560.19-0.17-0.560.40.410.710.010.56-0.68-0.630.17-0.34-0.8-0.57-0.26-0.22-0.540.080.420.280.230.54
-0.33-0.68-0.410.19-0.31-0.410.950.47-0.120.75-0.390.08-0.420.3-0.58-0.46-0.48-0.430.73-0.480.750.120.780.39-0.43
-0.130.03-0.09-0.17-0.31-0.09-0.370.1-0.13-0.130.23-0.01-0.080.22-0.040.41-0.03-0.22-0.13-0.08-0.130.42-0.09-0.460.08
0.990.921.0-0.56-0.41-0.09-0.41-0.51-0.54-0.29-0.570.70.99-0.30.610.640.990.81-0.120.99-0.4-0.58-0.67-0.51-0.17
-0.33-0.62-0.410.40.95-0.37-0.410.50.10.73-0.29-0.08-0.430.39-0.58-0.66-0.48-0.40.58-0.470.650.160.730.41-0.21
-0.49-0.53-0.510.410.470.1-0.510.50.270.65-0.03-0.33-0.50.58-0.63-0.45-0.51-0.720.53-0.560.710.740.710.18-0.02
-0.55-0.34-0.540.71-0.12-0.13-0.540.10.27-0.050.68-0.88-0.530.29-0.24-0.78-0.52-0.36-0.4-0.51-0.140.320.160.490.66
-0.22-0.49-0.290.010.75-0.13-0.290.730.65-0.05-0.350.03-0.250.7-0.72-0.33-0.32-0.630.7-0.370.690.440.680.16-0.36
-0.62-0.25-0.570.56-0.390.23-0.57-0.29-0.030.68-0.35-0.71-0.580.08-0.18-0.33-0.51-0.27-0.65-0.5-0.420.36-0.130.10.69
0.730.480.7-0.680.08-0.010.7-0.08-0.33-0.880.03-0.710.69-0.130.220.720.670.470.230.65-0.05-0.43-0.19-0.36-0.47
0.990.90.99-0.63-0.42-0.080.99-0.43-0.5-0.53-0.25-0.580.69-0.260.60.650.990.77-0.110.99-0.39-0.58-0.66-0.47-0.19
-0.24-0.32-0.30.170.30.22-0.30.390.580.290.70.08-0.13-0.26-0.65-0.33-0.28-0.630.12-0.350.170.580.480.140.15
0.560.650.61-0.34-0.58-0.040.61-0.58-0.63-0.24-0.72-0.180.220.6-0.650.440.620.8-0.420.67-0.53-0.64-0.68-0.3-0.05
0.610.620.64-0.8-0.460.410.64-0.66-0.45-0.78-0.33-0.330.720.65-0.330.440.680.45-0.040.65-0.29-0.28-0.52-0.65-0.35
0.980.950.99-0.57-0.48-0.030.99-0.48-0.51-0.52-0.32-0.510.670.99-0.280.620.680.8-0.180.99-0.45-0.54-0.71-0.56-0.14
0.780.810.81-0.26-0.43-0.220.81-0.4-0.72-0.36-0.63-0.270.470.77-0.630.80.450.8-0.420.85-0.6-0.8-0.76-0.410.0
-0.07-0.4-0.12-0.220.73-0.13-0.120.580.53-0.40.7-0.650.23-0.110.12-0.42-0.04-0.18-0.42-0.210.930.210.610.15-0.65
0.980.950.99-0.54-0.48-0.080.99-0.47-0.56-0.51-0.37-0.50.650.99-0.350.670.650.990.85-0.21-0.47-0.6-0.73-0.53-0.12
-0.36-0.6-0.40.080.75-0.13-0.40.650.71-0.140.69-0.42-0.05-0.390.17-0.53-0.29-0.45-0.60.93-0.470.410.790.26-0.54
-0.58-0.43-0.580.420.120.42-0.580.160.740.320.440.36-0.43-0.580.58-0.64-0.28-0.54-0.80.21-0.60.410.44-0.070.22
-0.61-0.84-0.670.280.78-0.09-0.670.730.710.160.68-0.13-0.19-0.660.48-0.68-0.52-0.71-0.760.61-0.730.790.440.54-0.36
-0.45-0.63-0.510.230.39-0.46-0.510.410.180.490.160.1-0.36-0.470.14-0.3-0.65-0.56-0.410.15-0.530.26-0.070.540.12
-0.190.1-0.170.54-0.430.08-0.17-0.21-0.020.66-0.360.69-0.47-0.190.15-0.05-0.35-0.140.0-0.65-0.12-0.540.22-0.360.12
Click cells to compare fundamentals

Bruker Account Relationship Matchups

Bruker fundamentals Accounts

202020212022202320242025 (projected)
Price To Sales Ratio4.185.254.013.632.595.09
Dividend Yield0.0029630.0019050.0029340.0027330.0034460.003274
Ptb Ratio8.5111.719.027.818.9814.38
Free Cash Flow Yield0.02830.0150.01410.02260.01530.0149
Operating Cash Flow Per Share2.171.871.762.391.691.77
Stock Based Compensation To Revenue0.008050.0071140.01090.0080960.0072860.007651
Capex To Depreciation0.971.221.031.350.930.61
Pb Ratio8.5111.719.027.818.9814.38
Free Cash Flow Per Share0.91.531.260.961.660.94
Roic0.130.0990.07790.110.09650.0566
Inventory Turnover1.511.71.521.51.351.26
Net Income Per Share1.271.031.832.02.920.76
Payables Turnover7.788.26.877.166.447.41
Research And Ddevelopement To Revenue0.09060.09960.09130.09320.09940.13
Capex To Revenue0.04940.0380.0470.03610.03490.0468
Pocfratio24.9244.9938.7730.7334.7736.51
Interest Coverage17.2428.926.8826.64(6.63)(6.29)
Payout Ratio0.160.08730.10.06880.270.18
Capex To Operating Cash Flow0.290.330.450.310.470.49
Pfcf Ratio35.3366.7271.0344.2365.2860.4
Income Quality2.061.010.880.822.211.85
Pe Ratio52.6245.8534.2425.1877.2381.77
Return On Tangible Assets0.110.0910.06610.09630.130.12
Earnings Yield0.0190.02180.02920.03970.01290.0164
Current Ratio2.432.632.321.82.072.44
Receivables Turnover5.935.84.254.774.294.46
Debt To Equity0.911.231.081.00.90.95
Capex Per Share0.640.610.80.730.790.83
Revenue Per Share12.9615.9717.0320.2522.5923.72
Debt To Assets0.160.310.290.370.340.32
Days Sales Outstanding61.5862.9385.8676.5688.0473.49
Book Value Per Share6.367.177.629.658.699.12
Ev To Sales4.285.364.243.934.525.21
Days Of Inventory On Hand241.18214.51239.47243.54280.07271.57
Cash Per Share4.777.725.023.343.01.79
Days Payables Outstanding46.8944.5353.1650.9858.6351.65

Pair Trading with Bruker

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bruker Stock

  0.72ME 23Andme HoldingPairCorr

Moving against Bruker Stock

  0.66DOMH Dominari HoldingsPairCorr
  0.65VIGL Vigil NeurosciencePairCorr
  0.62VALN Valneva SE ADRPairCorr
  0.45EQ EquilliumPairCorr
The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.
The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Bruker Stock Analysis

When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.

Trending Assets

FNA
Paragon 28
13.02  -0.03  -0.23 
ITGR
Integer Holdings Corp
129.87  -5.35  -3.96 
LUNG
Pulmonx Corp
8.96  0.18  2.05 
ZBH
Zimmer Biomet Holdings
104.83  1.20  1.16 
KIDS
Orthopediatrics Corp
23.76  -0.6  -2.46 
AXGN
Axogen Inc
18.00  -0.5  -2.7 
LIVN
LivaNova PLC
47.44  -0.55  -1.15 
SRDX
SurModics
34.85  0.47  1.37 
GKOS
Glaukos Corp
125.88  -31.48  -20.01 
IRTC
iRhythm Technologies
119.44  6.77  6.01 
AORT
Artivion
28.26  -0.56  -1.94 
BIO
Bio Rad Laboratories
280.08  -5.55  -1.94 
NUVA
NuVasive
0.00  0.00  0.00 
HSKA
Heska
0.00  0.00  0.00 
ELMD
Electromed
27.97  -0.66  -2.31 
OFIX
Orthofix Medical
17.95  -0.15  -0.83 
CNMD
CONMED
61.13  -0.18  -0.29 
News Freq…Investor S…